
Windlas Biotech Limited has informed the Exchange regarding a press release dated April 02, 2024, titled "Windlas Biotech Limited commissions its State-of-the-Art Injectable facility".
Filed with NSE ·

Windlas Biotech Limited has informed the Exchange regarding a press release dated April 02, 2024, titled "Windlas Biotech Limited commissions its State-of-the-Art Injectable facility".
6ix hasn’t read this filing yet.
Follow Windlas Biotech into a list and get an email when it puts out news.
Follow Windlas Biotech